Jennifer E Ding, Anisha Pradhan, Dorothy K Ma, Andrea J FazioLiu, Sarah M Chang, Andrew D Graham, Devin J Leung, Ryan S Wu, Yixiu Zhou, Tatyana Svitova, Thao N Yeh, Meng C Lin
{"title":"Randomized comparison of lipid-containing and non-lipid-containing artificial tears on tear film dynamics over a 3-month period.","authors":"Jennifer E Ding, Anisha Pradhan, Dorothy K Ma, Andrea J FazioLiu, Sarah M Chang, Andrew D Graham, Devin J Leung, Ryan S Wu, Yixiu Zhou, Tatyana Svitova, Thao N Yeh, Meng C Lin","doi":"10.1002/ovs2.70084","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To study the effects of a lipid-containing artificial tear (AT) and a non-lipid-containing AT on tear film dynamics over a 3-month period.</p><p><strong>Methods: </strong>Subjects with low lipid layer thickness were randomized to lipid-containing or non-lipid-containing ATs for 3 months. At each visit Ocular Surface Disease Index (OSDI), LipiView, non-invasive and fluorescein tear breakup times, tear lipid layer and aqueous film recordings with EasyTear View+, and corneal staining assessment were performed. Lipid layer thickness and tear thinning rate were calculated using custom LabView programs. Mixed effects models were used to analyze relationships among variables.</p><p><strong>Results: </strong>Thirty nine subjects completed the study. Mean EasyTear View+ lipid layer thickness with non-lipid-containing AT decreased from baseline (65.1 [61.0, 69.2] nm) to 3 months (58.0 [53.4, 62.7] nm, p = 0.012), whereas mean lipid layer thickness with the lipid-containing AT remained stable (baseline = 59.0 [53.6, 64.4] nm, 3 months = 62.4 [56.1, 68.7] nm, p = 0.30). There was a significant difference in lipid layer thickness change from baseline to 3 months between the lipid-containing (3.4 nm) and non-lipid-containing ATs (-7.1 nm, p = 0.014). Tear thinning rate with the non-lipid-containing AT was faster at 3 months (baseline = 3.01 [2.21, 3.81]%/sec, 3 months = 4.78 [3.62, 5.94]%/sec, p = 0.008), but remained stable with the lipid-containing AT (baseline = 2.84 [1.93, 3.76]%/sec, 3 months = 2.93 [2.15, 3.70]%/sec, p = 0.84). The increase in tear thinning rate from baseline was greater with the non-lipid-containing (1.77%/sec) than the lipid-containing AT (0.09%/sec, p = 0.019). Fluorescein tear breakup time with the non-lipid-containing AT remained stable at 3 months (4.70 [4.14, 5.25] sec) versus baseline (4.23 [3.48, 4.99] sec, p = 0.26), whereas fluorescein tear breakup time with the lipid-containing AT was longer at 3 months (6.33 [4.85, 7.82] sec) versus baseline (4.44 [3.66, 5.22] sec, p = 0.029). There were no significant changes in OSDI score, LipiView lipid layer thickness, non-invasive tear breakup time or corneal staining grade over the 3-month period.</p><p><strong>Conclusions: </strong>Patients with lipid deficiency may benefit from lipid-containing AT over the non-lipid-containing AT to stabilize tear lipid thickness and minimize tear thinning while increasing tear breakup time.</p><p><strong>Trial registration: </strong>This study was registered at ClinicalTrials.gov (#NCT05705518) on the date of January 20, 2023.</p>","PeriodicalId":520732,"journal":{"name":"Optometry and vision science : official publication of the American Academy of Optometry","volume":"103 7","pages":"e70084"},"PeriodicalIF":1.8000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Optometry and vision science : official publication of the American Academy of Optometry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/ovs2.70084","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: To study the effects of a lipid-containing artificial tear (AT) and a non-lipid-containing AT on tear film dynamics over a 3-month period.
Methods: Subjects with low lipid layer thickness were randomized to lipid-containing or non-lipid-containing ATs for 3 months. At each visit Ocular Surface Disease Index (OSDI), LipiView, non-invasive and fluorescein tear breakup times, tear lipid layer and aqueous film recordings with EasyTear View+, and corneal staining assessment were performed. Lipid layer thickness and tear thinning rate were calculated using custom LabView programs. Mixed effects models were used to analyze relationships among variables.
Results: Thirty nine subjects completed the study. Mean EasyTear View+ lipid layer thickness with non-lipid-containing AT decreased from baseline (65.1 [61.0, 69.2] nm) to 3 months (58.0 [53.4, 62.7] nm, p = 0.012), whereas mean lipid layer thickness with the lipid-containing AT remained stable (baseline = 59.0 [53.6, 64.4] nm, 3 months = 62.4 [56.1, 68.7] nm, p = 0.30). There was a significant difference in lipid layer thickness change from baseline to 3 months between the lipid-containing (3.4 nm) and non-lipid-containing ATs (-7.1 nm, p = 0.014). Tear thinning rate with the non-lipid-containing AT was faster at 3 months (baseline = 3.01 [2.21, 3.81]%/sec, 3 months = 4.78 [3.62, 5.94]%/sec, p = 0.008), but remained stable with the lipid-containing AT (baseline = 2.84 [1.93, 3.76]%/sec, 3 months = 2.93 [2.15, 3.70]%/sec, p = 0.84). The increase in tear thinning rate from baseline was greater with the non-lipid-containing (1.77%/sec) than the lipid-containing AT (0.09%/sec, p = 0.019). Fluorescein tear breakup time with the non-lipid-containing AT remained stable at 3 months (4.70 [4.14, 5.25] sec) versus baseline (4.23 [3.48, 4.99] sec, p = 0.26), whereas fluorescein tear breakup time with the lipid-containing AT was longer at 3 months (6.33 [4.85, 7.82] sec) versus baseline (4.44 [3.66, 5.22] sec, p = 0.029). There were no significant changes in OSDI score, LipiView lipid layer thickness, non-invasive tear breakup time or corneal staining grade over the 3-month period.
Conclusions: Patients with lipid deficiency may benefit from lipid-containing AT over the non-lipid-containing AT to stabilize tear lipid thickness and minimize tear thinning while increasing tear breakup time.
Trial registration: This study was registered at ClinicalTrials.gov (#NCT05705518) on the date of January 20, 2023.